AMD (NASDAQ: AMD) announced today that it will report fiscal fourth quarter and full year 2024 financial results on Tuesday, ...

AMD is no stranger to six-core CPUs — after all, even the Ryzen 5 9600X is still a six-core part, for better or worse. It has ...

AMD has also told us that it would release RDNA 4 in a matter of weeks. That could mean anything, but it also specified that ...

Benchmarks have leaked for AMD's Radeon RX 9070 XT showing RTX 4080 Super-level performance, which is impressive for a card slated to cost well under $1,000 ...

AMD's new Radeon RX 9070 XT 'RDNA 4' graphics card turns up on retailer website: teased Navi 48 XT GPU at nearly 3GHz, 16GB ...

Undervalued biotech company Regenxbio Inc. shows promise with cutting-edge gene therapy technology for AMD and MPS II. Click ...

To refine this long-term forecast, we analyzed the daily, H4, and H1 charts for our members. In December 2024, the stock ...

AMD's new Strix Halo uber APU for laptops was already pretty interesting, what with its 256-bit memory bus and monster sized ...

In the high-tech universe, there is a single common road that top-flight companies like Nvidia (NASDAQ: NVDA), Advanced Micro ...

The RTX 5090 is coming first and in less than two weeks we'll know just how fast it is in third party benchmark reviews ...

Q2 2025 Earnings Call Transcript January 13, 2025 Operator: Greetings. Welcome to the Aehr Test Systems Fiscal 2025 Second ...

About AXPAXLI AXPAXLI™ (axitinib intravitreal injection, also known as OTX-TKI) is an investigational, bioresorbable, hydrogel incorporating axitinib, a small molecule, multi-target, tyrosine kinase ...